Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Fujisawa describes cathepsin L/B inhibitor of fungal origin

April 19, 1996

Cortecs' oral salmon calcitonin shows favorable phase II results

April 19, 1996

Vivus files NDA for Muse

April 12, 1996

Testosterone transdermal patch approved in Sweden

April 12, 1996

Fujisawa in-licenses zenarestat

April 12, 1996

NT-3 shows potential in diabetic neuropathy

April 12, 1996

Selective protein kinase C beta antagonist discovered by Lilly

April 12, 1996

Anergen, Novo Nordisk expand diabetes collaboration

April 12, 1996

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

Sertoli Technologies formed to develop new technology

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...